Preliminary Experience of Routine Voriconazole Therapeutic Drug Monitoring (TDM) in a Tertiary Care Centre

Universitaire Ziekenhuizen KU Leuven

Status: Completed

Conditions: Patients Treated With Voriconazole

Study type: Observational

Funder types: Other

Identifiers

NCT01418833

ML7258

Details and patient eligibility

About

The first goal of this study is to map all the subtherapeutic, therapeutic and supratherapeutic voriconazole plasma levels in the University Hospitals Leuven. The second objective is to optimize and validate guidelines for dose modifications in patients with too low or high plasma concentrations and to investigate if the same guidelines can be used in different patient populations.

Enrollment: 160 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients treated with voriconazole
• at least 1 voriconazole plasma level measured during therapy

Exclusion criteria

• none